|
|
|
AFRICA: New nevirapine research challenges earlier findings
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 10 February (PLUSNEWS) - New research from the US Centres for Disease Control and Prevention (CDC) shows that the anti-AIDS drug, nevirapine, can prevent the spread of HIV from mother to child more than once.
The study, which observed 198 women between 2004 and 2005 in Uganda, demonstrated that expectant mothers who received the drug during a first pregnancy were also prevented from passing the virus to their unborn babies during second pregnancies.
Associated Press quoted CDC medical epidemiologist Dr Michael Thigpen as saying, "Based on these findings, we believe nevirapine in repeat pregnancies remains an effective option in these resource-limited countries."
The safety of the drug was brought into question after earlier studies in South Africa and Uganda found that 20 percent to 40 percent of HIV-positive women developed resistance to nevirapine after taking one dose to protect their newborns from becoming infected.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
|
|
|
|
|
|
|
| Links |
· AIDS Media Center
|
· The Global Fund to fight AIDS, Tuberculosis & Malaria
|
· International Community of Women Living with HIV/AIDS
|
· AEGIS
|
· International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster
Copyright © IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.
|
